Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avishay Elis

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Expert Review of Cardiovascular Therapy|August 17, 2012
Should HDL cholesterol levels be the primary target of cardiovascular disease risk assessment and therapy?Avishay Elis
European Journal of Internal Medicine|February 22, 2023
Current and future options in cholesterol lowering treatmentsAvishay Elis
European Journal of Internal Medicine|March 4, 2025
The prothrombotic effects of Lipoprotein (a) and atherosclerosisAvishay Elis
Harefuah|June 25, 2026
[Internal Medicine - My Mission]Avishay Elis
Harefuah|August 16, 2021
[RESEARCH AND CLINICAL PRACTICE- THE SOUL AND BREATH OF INTERNAL MEDICINE]Avishay Elis, Howard Amital
Harefuah|May 29, 2017
[THE TREATMENT OF HYPERTENSION BY FIXED DRUG COMBINATIONS IN PATIENTS HOSPITALIZED AT THE DEPARTMENT OF MEDICINE]Avishay Elis, Amit Akirov
Harefuah|January 27, 2005
[Composition of risk factors among acute myocardial infarction patients in Israel: sub-analysis of the Israeli National Prospective Survey on Acute Myocardial Infarction in 2000]Avishay Elis, Michael Lishner
The Israel Medical Association Journal : IMAJ|November 27, 2022
Welcome to the World of Israeli Internal MedicineHoward Amital, Avishay Elis
The Israel Medical Association Journal : IMAJ|December 18, 2024
Recurrent Cardiovascular Events Despite Optimal LDL-Cholesterol Reduction: Therapeutic ChallengesAvishay Elis, Ela Giladi
European Journal of Internal Medicine|June 11, 2025
The approach to triglyceride levels in patients with coronary heart diseaseIlay Shani, Avishay Elis
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Expert Review of Cardiovascular Therapy|August 17, 2012
Should HDL cholesterol levels be the primary target of cardiovascular disease risk assessment and therapy?Avishay Elis
European Journal of Internal Medicine|February 22, 2023
Current and future options in cholesterol lowering treatmentsAvishay Elis
European Journal of Internal Medicine|March 4, 2025
The prothrombotic effects of Lipoprotein (a) and atherosclerosisAvishay Elis
Harefuah|June 25, 2026
[Internal Medicine - My Mission]Avishay Elis
Harefuah|August 16, 2021
[RESEARCH AND CLINICAL PRACTICE- THE SOUL AND BREATH OF INTERNAL MEDICINE]Avishay Elis, Howard Amital
Harefuah|May 29, 2017
[THE TREATMENT OF HYPERTENSION BY FIXED DRUG COMBINATIONS IN PATIENTS HOSPITALIZED AT THE DEPARTMENT OF MEDICINE]Avishay Elis, Amit Akirov
Harefuah|January 27, 2005
[Composition of risk factors among acute myocardial infarction patients in Israel: sub-analysis of the Israeli National Prospective Survey on Acute Myocardial Infarction in 2000]Avishay Elis, Michael Lishner
The Israel Medical Association Journal : IMAJ|November 27, 2022
Welcome to the World of Israeli Internal MedicineHoward Amital, Avishay Elis
The Israel Medical Association Journal : IMAJ|December 18, 2024
Recurrent Cardiovascular Events Despite Optimal LDL-Cholesterol Reduction: Therapeutic ChallengesAvishay Elis, Ela Giladi
European Journal of Internal Medicine|June 11, 2025
The approach to triglyceride levels in patients with coronary heart diseaseIlay Shani, Avishay Elis
Pageof 10